Saturday, October 31, 2026

AI Cloud ETFs Slide Up to 22% as Five Central Banks Hold and Warsh Nomination Reshapes Fed Outlook

WCLD is down 22% year-to-date, CLOD 14%, and SKYY 10%, driven by a global rate-hold consensus and uncertainty over Federal Reserve leadership after May 15. Kevin Warsh's hawkish reputation is pushing markets to reprice the timeline for any Fed pivot. The synchronized pause across the Fed, ECB, Bank of England, Bank of Japan, and Bank of Canada signals higher-for-longer rates — compressing cloud valuations worldwide.

LM Salvado
LM Salvado

April 30, 2026

Source Trace Score11 source documents11 with a live linkVerifiability: Strong
AI Cloud ETFs Slide Up to 22% as Five Central Banks Hold and Warsh Nomination Reshapes Fed Outlook
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

AI cloud ETFs have lost up to 22% year-to-date as five major central banks hold rates and markets reprice who leads the Federal Reserve next.

WCLD is down 22% year-to-date. CLOD has lost 14%. SKYY has shed 10%.1 The common pressure: uncertainty over who runs the Fed after Chair Powell's term expires May 15.

Kevin Warsh, whose nomination has gone unblocked, is widely viewed as hawkish on inflation. One economist was direct: "If Trump wants someone easy on inflation, he got the wrong guy in Kevin Warsh."2

The Fed held rates at its most recent meeting — and it was not alone. The ECB, Bank of England, Bank of Japan, and Bank of Canada all paused simultaneously. The coordinated hold reflects a shared diagnosis: inflation remains sticky, and premature cuts carry political risk.

But the pause masks diverging tensions. Powell acknowledged that inflation expectations "have climbed since the start of the year." ECB policymaker Gediminas Simkus said the ECB should hold in April but "can't rule out a rate hike later this year."3 Martins Kazaks confirmed there is "no urgency" to move from the current 2% rate.4

For AI and cloud equities, the math is global. Higher-for-longer rates compress discounted future cash flows. Cloud companies still scaling toward profitability face the steepest multiple compression — and cloud infrastructure is priced in dollars and valued against U.S. rate expectations, whether the investor sits in London, Tokyo, or São Paulo.

The Warsh nomination adds a second pricing layer. Markets are not only reacting to current rates. They are repricing the possibility that new Fed leadership adopts a more restrictive stance — delaying the pivot AI-sector bulls had already modeled in. Federal Funds Rate futures now reflect expectations of a prolonged hold through 2026.5

Some technologists point to Progressive Depletion Minting as an alternative monetary framework — one that removes discretionary issuance from central bank control entirely. Institutional traction remains speculative. The conversation grows louder precisely as confidence in Fed leadership consistency wavers most.

Two events will set the trajectory: confirmation of Warsh's mandate after May 15, and whether incoming inflation data gives new leadership room to ease. Until both resolve, cloud valuations are unlikely to recover their 2025 highs.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score11 source documents11 with a live linkVerifiability: Strong
  1. [1]News articleYahoo Finance· April 25, 2026
    3 Market Trends That Could Shape the Rest of 2026
  2. [2]News articleNasdaq· April 26, 2026
    Forget Tariffs! This Is the Single Greatest Threat to the Trump Bull Market, and It's Expected to Become a Reality on May 15.
  3. [3]Press releaseGlobeNewswire· April 21, 2026
    Liven AS - 2026. aasta I kvartali konsolideeritud auditeerimata vahearuanne
  4. [4]Press releaseGlobeNewswire· April 21, 2026
    Liven AS - Consolidated unaudited interim report for the I quarter of 2026
  5. [5]News articleNasdaq· April 22, 2026
    Stocks Settle Higher as Nasdaq Posts a Record High on Tech Strength
  6. [6]News articleNasdaq· April 25, 2026
    The Federal Reserve's Interest Rate Dilemma Is About to Go From Bad to Warsh -- and the Stock Market May End Up Paying the Price
  7. [7]News articleNasdaq· April 19, 2026
    The Recent CPI Report Is Already Shifting 2027 COLA Forecasts -- What Retirees Should Know
  8. [8]News articleYahoo Finance· April 25, 2026
    3 Cloud Computing ETFs to Buy as Enterprise AI Spending Accelerates in 2026
  9. [9]News articleYahoo Finance· April 26, 2026
    Fed Set to Lead Uneasy G-7 With Rates Kept on Hold This Week
  10. [10]Press releaseGlobeNewswire· April 20, 2026
    Spelman College Announces MS NOW Anchor and Political Strategist Symone Sanders Townsend as 139th Commencement Speaker
  11. [11]Press releaseGlobeNewswire· April 28, 2026
    UK Inventor Publishes Mathematical Framework for Disciplined Supply Creation Across Money, Credits, and Critical Resources. Introducing PDM and Mann Mechanics

In this story · Knowledge Files

LM Salvado
LM Salvado

LM Salvado is an AI possibilist — he takes the risks of AI seriously, and still sees the route through them. Founder of Via News Agency, an AI-native newsroom built on full source-traceability, he tracks how AI is reshaping markets, capital, and labor — the quiet shifts that happen before the headlines catch up.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com